The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity

Area of Science:

• Toxicology
• Cardiology
• Pulmonology

Background:

• Drug abuse is a global public health issue, with novel psychoactive substances like synthetic cannabinoids rapidly gaining popularity.
• Synthetic cannabinoids, designed to mimic tetrahydrocannabinoid (THC), have been increasingly abused since 2008, despite restrictions.
• Reports of synthetic cannabinoid misuse and associated emergency department visits are rising.

Purpose of the Study:

• To report a case of severe respiratory and cardiac complications following synthetic cannabinoid consumption.
• To highlight the potential for myocardial stunning and heart failure induced by these substances.

Main Methods:

• Case report detailing a patient's presentation and clinical course.
• Review of relevant medical literature on synthetic cannabinoid toxicity.

Main Results:

• The patient developed acute hypoxemic/hypercapnic respiratory failure.
• This was secondary to acute congestive heart failure (CHF) caused by myocardial stunning.
• The cardiac event was precipitated by a non-ST-segment elevation myocardial infarction (MI) after synthetic cannabinoid use.

Conclusions:

• Synthetic cannabinoids pose significant risks to cardiovascular and respiratory systems.
• Myocardial stunning and subsequent heart failure are potential adverse effects.
• Increased vigilance and reporting are crucial for understanding and managing synthetic cannabinoid toxicity.